BioNTech SE (BNTX) Non-Current Deferred Tax Liability (2020 - 2025)

BioNTech SE (BNTX) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $98.1 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Deferred Tax Liability rose 116.58% year-over-year to $98.1 million; the trailing twelve-month figure through Dec 2025 stood at $98.1 million (up 116.58% YoY), and the FY2025 full-year result was $95.2 million, up 110.21% from the prior year.
• Non-Current Deferred Tax Liability advanced to $98.1 million in Q4 2025, from $28.3 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $107.1 million in Q2 2022 to a low of $4.9 million in Q2 2023.
• A 5-year average of $42.9 million and a median of $42.7 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability jumped 31898.45% in 2021 and slumped 95.43% in 2023, its largest moves.
• Tracing BNTX's Non-Current Deferred Tax Liability over 5 years: stood at $76.3 million in 2021, then tumbled by 91.71% to $6.3 million in 2022, then soared by 575.28% to $42.7 million in 2023, then advanced by 6.07% to $45.3 million in 2024, then jumped by 116.58% to $98.1 million in 2025.
• Business Quant data shows BNTX's Non-Current Deferred Tax Liability at $98.1 million in Q4 2025, $28.3 million in Q3 2025, and $32.3 million in Q2 2025.